View Future GrowthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsMTL Cannabis 과거 순이익 실적과거 기준 점검 0/6MTL Cannabis은 연평균 9%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 9.7%의 비율로 증가했습니다. 매출은 연평균 33.5%의 비율로 증가했습니다.핵심 정보8.99%순이익 성장률70.45%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률5.95%매출 성장률33.47%자기자본이익률-13.27%순이익률-3.83%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025모든 업데이트 보기Recent updates공시 • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.공시 • Sep 10MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025.공시 • Aug 19MTL Cannabis Corp. announced that it expects to receive CAD 4 million in fundingMTL Cannabis Corp. announced that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent” or “C1C”) as lead agent and sole bookrunner, in connection with a brokered private placement of units on a commercially reasonable efforts basis to issue 6,153,846 units at an issue price of CAD 0.65 for gross proceeds of CAD3,999,999.9 on August 19, 2025. The Lead Agent will have the option to sell up to an additional CAD 1,750,000 in Units (the “Agents’ Option”), exercisable at any time up to 48 hours prior to the closing date. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each Warrant will entitle the holder to acquire one Common Share at an exercise price equal to a price of CAD 0.98 for a period of three years following the date of issuance. It is anticipated that certain insiders of the Company, the Lead Agent and certain affiliates may acquire Units in the Offering in amounts up to approximately 25% of the Offering. The securities issued under the LIFE Exemption will not be subject to a statutory hold period pursuant to applicable Canadian securities laws. The Offering is expected to close on or about August 22, 2025, or such other date as the Company and the Lead Agent may agree, and may close in one or more tranches. Closing is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). The Units will be offered for sale in the provinces of British Columbia, Alberta, and Ontario, and such other jurisdictions outside of Canada and in the United States as may be agreed to by the Lead Agent and the Company. In the United States, the Units will be offered on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended, and only to “accredited investors” as defined in Regulation D thereunder. The Offering will be conducted under the listed issuer financing exemption (the “LIFE Exemption”) pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions and Canadian Securities Administrators Coordinated Blanket Order 45-953 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption.공시 • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025공시 • Oct 15MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024.매출 및 비용 세부 내역MTL Cannabis가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:MTLN.F 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비31 Dec 2581-328030 Sep 2584-528030 Jun 2584526031 Mar 2584727031 Dec 2476125030 Sep 2475325030 Jun 2473522031 Mar 2465218031 Dec 2359314030 Sep 2347112030 Jun 2332-39031 Mar 2325-28031 Dec 2222-510031 Mar 222228031 Mar 2113130양질의 수익: MTLN.F 은(는) 현재 수익성이 없습니다.이익 마진 증가: MTLN.F는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: MTLN.F는 수익성이 없지만 지난 5년 동안 연평균 9%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 MTLN.F의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: MTLN.F은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(-5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: MTLN.F는 현재 수익성이 없으므로 자본 수익률이 음수(-13.27%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/03/16 02:20종가2026/03/03 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MTL Cannabis Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025
공시 • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.
공시 • Sep 10MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025.
공시 • Aug 19MTL Cannabis Corp. announced that it expects to receive CAD 4 million in fundingMTL Cannabis Corp. announced that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent” or “C1C”) as lead agent and sole bookrunner, in connection with a brokered private placement of units on a commercially reasonable efforts basis to issue 6,153,846 units at an issue price of CAD 0.65 for gross proceeds of CAD3,999,999.9 on August 19, 2025. The Lead Agent will have the option to sell up to an additional CAD 1,750,000 in Units (the “Agents’ Option”), exercisable at any time up to 48 hours prior to the closing date. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each Warrant will entitle the holder to acquire one Common Share at an exercise price equal to a price of CAD 0.98 for a period of three years following the date of issuance. It is anticipated that certain insiders of the Company, the Lead Agent and certain affiliates may acquire Units in the Offering in amounts up to approximately 25% of the Offering. The securities issued under the LIFE Exemption will not be subject to a statutory hold period pursuant to applicable Canadian securities laws. The Offering is expected to close on or about August 22, 2025, or such other date as the Company and the Lead Agent may agree, and may close in one or more tranches. Closing is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). The Units will be offered for sale in the provinces of British Columbia, Alberta, and Ontario, and such other jurisdictions outside of Canada and in the United States as may be agreed to by the Lead Agent and the Company. In the United States, the Units will be offered on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended, and only to “accredited investors” as defined in Regulation D thereunder. The Offering will be conducted under the listed issuer financing exemption (the “LIFE Exemption”) pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions and Canadian Securities Administrators Coordinated Blanket Order 45-953 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption.
공시 • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025
공시 • Oct 15MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024.